Lactitol PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Lactitol PCD pharma franchise company offering 3 formulations in granule and suspension forms. Manufactured at WHO-GMP certified facilities, this range gives franchise partners a well-tolerated osmotic laxative for chronic constipation and liver-support therapy.
What is Lactitol?
Lactitol is a second-generation disaccharide osmotic laxative. It is not absorbed in the small intestine and reaches the colon largely intact, where it draws water into the bowel and is fermented by colonic bacteria to lower luminal pH. This softens the stool, promotes bowel movement and, in liver disease, reduces the absorption of ammonia. Learn more on PubChem.
Therapeutic Applications of Lactitol
Lactitol is used for the treatment of chronic constipation and for the prevention and management of hepatic encephalopathy in patients with chronic liver disease. It is prescribed by gastroenterologists, hepatologists and general physicians.
Why Lactitol is a High-Potential Molecule for Distributors
Chronic constipation is a large and under-treated problem in India, especially among the elderly and sedentary population, and gentle osmotic laxatives are increasingly preferred over stimulant options. Lactitol’s dual role in constipation and hepatic encephalopathy adds a specialist-driven segment on top of everyday demand, giving distributors a steady, repeat-purchase gastro-intestinal molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.
References
- PubChem – Lactitol Compound Summary, U.S. National Library of Medicine
- PubMed – Clinical literature on Lactitol
Our formulations of Lactitol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: